- Home
- HSTM
HSTM
HealthStream Inc.
as of 07-10-2026 3:41pm EST
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 700.0M | IPO Year: | 1999 |
| Target Price: | $28.00 | AVG Volume (30 days): | 192.0K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | semi-annual | |
| EPS: | 0.20 | EPS Growth: | -7.58 |
| 52 Week Low/High: | $19.50 - $30.00 | Next Earning Date: | 05-04-2026 |
| Revenue: | $304,064,000 | Revenue Growth: | 4.26% |
| Revenue Growth (this year): | 9.45% | Revenue Growth (next year): | 5.12% |
| P/E Ratio: | 140.10 | Index: | N/A |
| Free Cash Flow: | 59.6M | FCF Growth: | +6.00% |
AI-Powered HSTM Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of HealthStream Inc. (HSTM)
Director
Avg Cost/Share
$29.00
Shares
6,000
Total Value
$174,000.00
Owned After
51,329
SEC Form 4
Director
Avg Cost/Share
$25.00
Shares
2,000
Total Value
$50,000.00
Owned After
51,329
SEC Form 4
Director
Avg Cost/Share
$25.00
Shares
2,000
Total Value
$50,000.00
Owned After
51,329
SEC Form 4
Executive Vice President
Avg Cost/Share
$24.08
Shares
3,000
Total Value
$72,229.50
Owned After
20,982
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| REBROVICK LINDA | HSTM | Director | Jul 6, 2026 | Sell | $29.00 | 6,000 | $174,000.00 | 51,329 | |
| REBROVICK LINDA | HSTM | Director | Jun 1, 2026 | Sell | $25.00 | 2,000 | $50,000.00 | 51,329 | |
| REBROVICK LINDA | HSTM | Director | May 28, 2026 | Sell | $25.00 | 2,000 | $50,000.00 | 51,329 | |
| O'Hara Kevin P | HSTM | Executive Vice President | May 20, 2026 | Sell | $24.08 | 3,000 | $72,229.50 | 20,982 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 23, 2026 · 100% conf.
Q4 2025 Earnings
8-K SELLFeb 23, 2026 · 100% conf.
1D
-3.69%
$20.46
Act: +4.00%
5D
-4.23%
$20.34
Act: +0.61%
20D
-3.68%
$20.46
hstm20251021_8k.htm
false 0001095565
0001095565
2025-12-31 2025-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 23, 2026 (February 23, 2026)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 23, 2026, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2025 and provided guidance for the full year 2026, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 23, 2026, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2025 and provided guidance for the full year 2026, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 23, 2026, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.035 per share of the Company’s outstanding common stock, which dividend will be payable on March 20, 2026 to holders of record on March 9, 2026.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 23, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 23, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 23, 2026
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 3, 2025
Q3 2025 Earnings
8-KNov 3, 2025
hstm20250819_8k.htm
false 0001095565
0001095565
2025-11-03 2025-11-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 3, 2025 (November 3, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 3, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On November 3, 2025 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On November 3, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on November 28, 2025 to holders of record on November 17, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated November 3, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated November 3, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: November 3, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 4, 2025
Q2 2025 Earnings
8-KAug 4, 2025
hstm20250603_8k.htm
false 0001095565
0001095565
2025-08-04 2025-08-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2025 (August 4, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 4, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On August 4, 2025 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On August 4, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on August 29, 2025 to holders of record on August 18, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated August 4, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated August 4, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: August 4, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2025 Q1 Q1 2025 Earnings
8-K May 5, 2025
Q1 2025 Earnings
8-KMay 5, 2025
hstm20250107_8k.htm
false 0001095565
0001095565
2025-05-05 2025-05-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 5, 2025 (May 5, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On May 5, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On May 5, 2025 the Company issued a press release announcing results of operations for the first quarter ended March 31, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On May 5, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on May 30, 2025 to holders of record on May 19, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated May 5, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated May 5, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: May 5, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2024 Q4 Q4 2024 Earnings
8-K Feb 24, 2025
Q4 2024 Earnings
8-KFeb 24, 2025
hstm20240926_8k.htm
false 0001095565
0001095565
2025-02-24 2025-02-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 24, 2025 (February 24, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 24, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2024 and provided guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 24, 2025, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2024 and provided guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 24, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on March 21, 2025 to holders of record on March 10, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 24, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 24, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 24, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2024 Q3 Q3 2024 Earnings
8-K Oct 21, 2024
Q3 2024 Earnings
8-KOct 21, 2024
hstm20240809_8k.htm
false 0001095565
0001095565
2024-10-21 2024-10-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 21, 2024 (October 21, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 21, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On October 21, 2024 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On October 21, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on November 15, 2024 to holders of record on November 4, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 21, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 21, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 21, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2024 Q2 Q2 2024 Earnings
8-K Jul 22, 2024
Q2 2024 Earnings
8-KJul 22, 2024
hstm20240530c_8k.htm
false 0001095565
0001095565
2024-07-22 2024-07-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 22, 2024 (July 22, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 22, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On July 22, 2024 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On July 22, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on August 16, 2024 to holders of record on August 5, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 22, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2024 Q1 Q1 2024 Earnings
8-K Apr 22, 2024
Q1 2024 Earnings
8-KApr 22, 2024
hstm20240311_8k.htm
false 0001095565
0001095565
2024-04-22 2024-04-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 22, 2024 (April 22, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 22, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2024 and reaffirming guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On April 22, 2024 the Company issued a press release announcing results of operations for the first quarter ended March 31, 2024 and reaffirming guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On April 22, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on May 17, 2024 to holders of record on May 6, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 22, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2023 Q4 Q4 2023 Earnings
8-K Feb 20, 2024
Q4 2023 Earnings
8-KFeb 20, 2024
hstm20231116_8k.htm
false 0001095565
0001095565
2024-02-19 2024-02-19
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 20, 2024 (February 19, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 19, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2023 and provided guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 19, 2024, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2023 and provided guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 19, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on March 22, 2024 to holders of record on March 11, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 19, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 19, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 20, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2023 Q3 Q3 2023 Earnings
8-K Oct 23, 2023
Q3 2023 Earnings
8-KOct 23, 2023
hstm20230829_8k.htm
false 0001095565
0001095565
2023-10-23 2023-10-23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 23, 2023 (October 23, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 23, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2023 and updated guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On October 23, 2023 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2023 and updated guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On October 23, 2023, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.025 per share of the Company’s outstanding common stock, which dividend will be payable on December 22, 2023 to holders of record on December 11, 2023.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 23, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 23, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 23, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2023 Q2 Q2 2023 Earnings
8-K Jul 24, 2023
Q2 2023 Earnings
8-KJul 24, 2023
hstm20230512_8k.htm
false 0001095565
0001095565
2023-07-24 2023-07-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 24, 2023 (July 24, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 24, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On July 24, 2023 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On July 24, 2023, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.025 per share of the Company’s outstanding common stock, which dividend will be payable on September 29, 2023 to holders of record on September 18, 2023.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 24, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2023 Q1 Q1 2023 Earnings
8-K Apr 24, 2023
Q1 2023 Earnings
8-KApr 24, 2023
hstm20230206_8k.htm
false 0001095565
0001095565
2023-04-24 2023-04-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 24, 2023 (April 24, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 24, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On April 24, 2023 the Company issued a press release announcing results of operations for the first quarter ended March 31, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On April 24, 2023, we announced that the our Board of Directors declared the Company’s second quarterly cash dividend under its dividend policy in the amount of $0.025 per share of the Company’s outstanding common stock, which dividend will be payable on June 23, 2023 to holders of record on June 12, 2023.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 24, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2022 Q4 Q4 2022 Earnings
8-K Feb 21, 2023
Q4 2022 Earnings
8-KFeb 21, 2023
hstm20221013_8k.htm
false 0001095565
0001095565
2023-02-20 2023-02-20
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 21, 2023 (February 20, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 20, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2022 and provided guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 20, 2023, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2022 and provided guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 20, 2023, we announced that our Board of Directors adopted a quarterly cash dividend policy, with an initial quarterly dividend of $0.025 per share, with the initial dividend being payable on April 28, 2023 to holders of record on April 17, 2023, and expected aggregate fiscal 2023 dividends of approximately $3.0 million.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 20, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 20, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 21, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2022 Q3 Q3 2022 Earnings
8-K Oct 24, 2022
Q3 2022 Earnings
8-KOct 24, 2022
hstm20220816_8k.htm
false 0001095565
0001095565
2022-10-24 2022-10-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 24, 2022 (October 24, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 24, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2022 and updated guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On October 24, 2022 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2022 and updated guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 24, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 24, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 24, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2022 Q2 Q2 2022 Earnings
8-K Jul 25, 2022
Q2 2022 Earnings
8-KJul 25, 2022
hstm20220519_8k.htm
false 0001095565
0001095565
2022-07-25 2022-07-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 25, 2022 (July 25, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 25, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2022 and reaffirming guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On July 25, 2022 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2022 and reaffirming guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 25, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2022 Q1 Q1 2022 Earnings
8-K Apr 25, 2022
Q1 2022 Earnings
8-KApr 25, 2022
hstm20220303_8k.htm
false 0001095565
0001095565
2022-04-25 2022-04-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2022 (April 25, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 25, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2022 and reiterates guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On April 25, 2022, the Company issued a press release announcing results of operations for the first quarter ended March 31, 2022 and reiterates guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 25, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2021 Q4 Q4 2021 Earnings
8-K Feb 22, 2022
Q4 2021 Earnings
8-KFeb 22, 2022
hstm20211230_8k.htm
false 0001095565
0001095565
2022-02-21 2022-02-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 22, 2022 (February 21, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 21, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full-year ended December 31, 2021 and provided guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 21, 2022, the Company issued a press release announcing results of operations for the fourth quarter and full-year ended December 31, 2021 and provided guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 21, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 21, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 22, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2021 Q3 Q3 2021 Earnings
8-K Oct 25, 2021
Q3 2021 Earnings
8-KOct 25, 2021
hstm20210924_8k.htm
false 0001095565
0001095565
2021-10-25 2021-10-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 25, 2021 (October 25, 2021)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 25, 2021, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On October 25, 2021, the Company issued a press release announcing results of operations for the third quarter ended September 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 25, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 25, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 25, 2021
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2021 Q2 Q2 2021 Earnings
8-K Jul 26, 2021
Q2 2021 Earnings
8-KJul 26, 2021
hstm-8k_20210726.htm
false 0001095565
0001095565
2021-07-26 2021-07-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 26, 2021 (July 26, 2021)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 26, 2021, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On July 26, 2021, the Company issued a press release announcing results of operations for the second quarter ended June 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 26, 2021
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
2021 Q1 Q1 2021 Earnings
8-K Apr 26, 2021
Q1 2021 Earnings
8-KApr 26, 2021
hstm-8k_20210426.htm
false 0001095565
0001095565
2021-04-26 2021-04-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 26, 2021 (April 26, 2021)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
HSTM
Nasdaq Global Select Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 26, 2021, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On April 26, 2021, the Company issued a press release announcing results of operations for the first quarter ended March 31, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 26, 2021
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Compare HSTM vs Leading Stocks
See how HSTM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HSTM HealthStream Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.